Cannell & Spears’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
Other funds holding HOLX
HI
Cannell & Spears's HOLX Position: Q1 2026 in Review
Cannell & Spears sold out of Hologic (HOLX) in Q1 2026, closing a stake of 3,452 shares — an estimated $257K sold.
Cannell & Spears first reported a position in HOLX in Q4 2017 and held it in 24 quarters. The position peaked at $351K in Q1 2021. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.
- Cannell & Spears reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
- Cannell & Spears sold 3,452 Hologic shares in Q1 2026, an estimated $257K.
- Cannell & Spears first reported a position in Hologic in Q4 2017 and held it in 24 quarters.
- Cannell & Spears's Hologic position peaked at $351K in Q1 2021.
- 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.
Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.